Literature DB >> 19460753

VLA-5-mediated adhesion to fibronectin accelerates hemin-stimulated erythroid differentiation of K562 cells through induction of VLA-4 expression.

Rika Tanaka1, Toshiyuki Owaki, Sadahiro Kamiya, Takuya Matsunaga, Kazuya Shimoda, Hiroaki Kodama, Ryo Hayashi, Takashi Abe, Yosei P Harada, Motoyuki Shimonaka, Hirofumi Yajima, Hiroshi Terada, Fumio Fukai.   

Abstract

Fibronectin plays important roles in erythropoiesis through the fibronectin receptors VLA-4 and VLA-5. However, the substantial role of these fibronectin receptors and their functional assignment in erythroid differentiation are not yet fully understood. Here, we investigated the effects of cell adhesion to fibronectin on erythroid differentiation using K562 human erythroid progenitor cells. Erythroid differentiation could be induced in K562 cells in suspension by stimulating with hemin. This hemin-stimulated erythroid differentiation was highly accelerated when cells were induced to adhere to fibronectin by treatment with TNIIIA2, a peptide derived from tenascin-C, which has recently been found to induce beta1-integrin activation. Another integrin activator, Mn(2+), also accelerated hemin-stimulated erythroid differentiation. Adhesive interaction with fibronectin via VLA-4 as well as VLA-5 was responsible for acceleration of the hemin-stimulated erythroid differentiation in response to TNIIIA2, although K562 cells should have been lacking in VLA-4. Adhesion to fibronectin forced by TNIIIA2 causally induced VLA-4 expression in K562 cells, and this was blocked by the RGD peptide, an antagonist for VLA-5. The resulting adhesive interaction with fibronectin via VLA-4 strongly enhanced the hemin-stimulated activation of p38 mitogen-activated protein kinase, which was shown to serve as a signaling molecule crucial for erythroid differentiation. Suppression of VLA-4 expression by RNA interference abrogated acceleration of hemin-stimulated erythroid differentiation in response to TNIIIA2. Thus, VLA-4 and VLA-5 may contribute to erythropoiesis at different stages of erythroid differentiation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19460753      PMCID: PMC2740407          DOI: 10.1074/jbc.M109.009860

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

1.  A critical role of VLA-4 in erythropoiesis in vivo.

Authors:  K Hamamura; H Matsuda; Y Takeuchi; S Habu; H Yagita; K Okumura
Journal:  Blood       Date:  1996-03-15       Impact factor: 22.113

2.  Cyclic nucleotide response element binding (CREB) protein activation is involved in K562 erythroleukemia cells differentiation.

Authors:  Roberta Di Pietro; Viviana di Giacomo; Luciana Caravatta; Silvia Sancilio; Rosa Alba Rana; Amelia Cataldi
Journal:  J Cell Biochem       Date:  2007-03-01       Impact factor: 4.429

3.  Growth factors and cytokines upregulate gelatinase expression in bone marrow CD34(+) cells and their transmigration through reconstituted basement membrane.

Authors:  A Janowska-Wieczorek; L A Marquez; J M Nabholtz; M L Cabuhat; J Montaño; H Chang; J Rozmus; J A Russell; D R Edwards; A R Turner
Journal:  Blood       Date:  1999-05-15       Impact factor: 22.113

4.  Fibronectin peptides derived from two distinct regions stimulate adipocyte differentiation by preventing fibronectin matrix assembly.

Authors:  Sadahiro Kamiya; Rina Kato; Masayoshi Wakabayashi; Takehiro Tohyama; Isao Enami; Masaaki Ueki; Hirofumi Yajima; Tadahiro Ishii; Hiroshi Nakamura; Takashi Katayama; Junichi Takagi; Fumio Fukai
Journal:  Biochemistry       Date:  2002-03-05       Impact factor: 3.162

5.  Identification of the anti-adhesive site buried within the heparin-binding domain of fibronectin.

Authors:  F Fukai; S Hasebe; M Ueki; M Mutoh; C Ohgi; H Takahashi; K Takeda; T Katayama
Journal:  J Biochem       Date:  1997-02       Impact factor: 3.387

6.  Expression of tenascin in developing and adult mouse lymphoid organs.

Authors:  G Ocklind; J Talts; R Fässler; A Mattsson; P Ekblom
Journal:  J Histochem Cytochem       Date:  1993-08       Impact factor: 2.479

7.  Fibronectin harbors anticell adhesive activity.

Authors:  F Fukai; H Takahashi; Y Habu; N Kubushiro; T Katayama
Journal:  Biochem Biophys Res Commun       Date:  1996-03-18       Impact factor: 3.575

Review 8.  Tenascin-C, tenascin-R and tenascin-X: a family of talented proteins in search of functions.

Authors:  H P Erickson
Journal:  Curr Opin Cell Biol       Date:  1993-10       Impact factor: 8.382

9.  Alpha4beta1 integrin and erythropoietin mediate temporally distinct steps in erythropoiesis: integrins in red cell development.

Authors:  Shawdee Eshghi; Mariette G Vogelezang; Richard O Hynes; Linda G Griffith; Harvey F Lodish
Journal:  J Cell Biol       Date:  2007-06-04       Impact factor: 10.539

10.  Concerted action of tenascin-C domains in cell adhesion, anti-adhesion and promotion of neurite outgrowth.

Authors:  D Fischer; M Brown-Lüdi; T Schulthess; R Chiquet-Ehrismann
Journal:  J Cell Sci       Date:  1997-07       Impact factor: 5.285

View more
  11 in total

1.  Combinatorial and distinct roles of α₅ and α₄ integrins in stress erythropoiesis in mice.

Authors:  Tatiana Ulyanova; Yi Jiang; Steven Padilla; Betty Nakamoto; Thalia Papayannopoulou
Journal:  Blood       Date:  2010-10-18       Impact factor: 22.113

2.  Tenascin-C-derived peptide TNIIIA2 highly enhances cell survival and platelet-derived growth factor (PDGF)-dependent cell proliferation through potentiated and sustained activation of integrin α5β1.

Authors:  Rika Tanaka; Yutaka Seki; Yohei Saito; Sadahiro Kamiya; Motomichi Fujita; Hiroaki Okutsu; Takuya Iyoda; Tatsuya Takai; Toshiyuki Owaki; Hirofumi Yajima; Junichi Taira; Ryo Hayashi; Hiroaki Kodama; Takuya Matsunaga; Fumio Fukai
Journal:  J Biol Chem       Date:  2014-05-07       Impact factor: 5.157

Review 3.  The role of extracellular matrix stiffness in megakaryocyte and platelet development and function.

Authors:  Orly Leiva; Catherine Leon; Seng Kah Ng; Pierre Mangin; Christian Gachet; Katya Ravid
Journal:  Am J Hematol       Date:  2018-01-12       Impact factor: 10.047

4.  Modulation of Tumor Cell Survival, Proliferation, and Differentiation by the Peptide Derived from Tenascin-C: Implication of β1-Integrin Activation.

Authors:  Takuya Iyoda; Fumio Fukai
Journal:  Int J Cell Biol       Date:  2011-12-19

5.  9-cis-retinoic Acid and troglitazone impacts cellular adhesion, proliferation, and integrin expression in K562 cells.

Authors:  Amanda M Hanson; Jessica Gambill; Venusa Phomakay; C Tyler Staten; Melissa D Kelley
Journal:  PLoS One       Date:  2014-03-26       Impact factor: 3.240

Review 6.  Involvement of Integrin-Activating Peptides Derived from Tenascin-C in Cancer Aggression and New Anticancer Strategy Using the Fibronectin-Derived Integrin-Inactivating Peptide.

Authors:  Motomichi Fujita; Manabu Sasada; Takuya Iyoda; Fumio Fukai
Journal:  Molecules       Date:  2020-07-16       Impact factor: 4.411

7.  Peptide TNIIIA2 Derived from Tenascin-C Contributes to Malignant Progression in Colitis-Associated Colorectal Cancer via β1-Integrin Activation in Fibroblasts.

Authors:  Motomichi Fujita; Yuka Ito-Fujita; Takuya Iyoda; Manabu Sasada; Yuko Okada; Kazuma Ishibashi; Takuro Osawa; Hiroaki Kodama; Fumio Fukai; Hideo Suzuki
Journal:  Int J Mol Sci       Date:  2019-06-05       Impact factor: 5.923

8.  Controlled delivery of β-globin-targeting TALENs and CRISPR/Cas9 into mammalian cells for genome editing using microinjection.

Authors:  Renee N Cottle; Ciaran M Lee; David Archer; Gang Bao
Journal:  Sci Rep       Date:  2015-11-12       Impact factor: 4.379

9.  Extra-cellular matrix proteins induce matrix metalloproteinase-1 (MMP-1) activity and increase airway smooth muscle contraction in asthma.

Authors:  Natasha K Rogers; Debbie Clements; Arundhati Dongre; Tim W Harrison; Dominic Shaw; Simon R Johnson
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

10.  EDA-Fibronectin Originating from Osteoblasts Inhibits the Immune Response against Cancer.

Authors:  Stephanie Rossnagl; Eva Altrock; Carla Sens; Sabrina Kraft; Katrin Rau; Michael D Milsom; Thomas Giese; Yvonne Samstag; Inaam A Nakchbandi
Journal:  PLoS Biol       Date:  2016-09-21       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.